Susanne A. Schneider

Johannes Gutenberg University Mainz — Germany

Medicine · Health Sciences

59h-index11.9kcitations690works5.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurological disorders and treatments(100), Genetic Neurodegenerative Diseases(77), Neurological diseases and metabolism(77), Parkinson's Disease Mechanisms and Treatments(71), Metabolism and Genetic Disorders(53)

Publications689 total

Exposition systémique négligeable au delgocitinib chez les patients utilisant le delgocitinib en crème à dose maximale pour le traitement d’un eczéma chronique des mains
Annales de Dermatologie et de Vénéréologie - FMC·2025
« Super-réponse » après traitement par delgocitinib 20 mg/g en crème dans un sous-groupe de patients atteints d’eczéma chronique des mains modéré à sévère
Annales de Dermatologie et de Vénéréologie - FMC·2025
Parkinson-Erkrankung und ambulante Versorgung
Nervenheilkunde·2025
Current Perspectives and Practices in Infection‐Related Movement Disorders (<scp>IRMD</scp>): Insights from a Survey of Members of the International Parkinson and Movement Disorder Society
Movement Disorders Clinical Practice·2025
Heterozygosity in NPC may be associated with neurologic and systemic phenotypes
Frontiers in Neurology·2025Open Access
Characteristics and Validity of Commercially Available Technologies Analyzing Voice Features to Assess Parkinson's Disease
Movement Disorders Clinical Practice·2025Open Access
Tuberculosis Related Movement Disorders: A Systematic Scoping Review Highlighting Geographic Disparities, Phenotypic Patterns, Treatment Responses, and Knowledge Gaps in Global Reporting
Movement Disorders Clinical Practice·2025· 3 cited
Einsatz von Kaliumpolyaspartat und Carboxymethylcellulose zur Vermeidung kristalliner Ausscheidungen bei Traubensaft
Mitteilungen Klosterneuburg·2025Open Access
Application of a natural history study on an investigational drug clinical development
Molecular Genetics and Metabolism·2025
Anticipatory humanitarian action
2025· 1 cited
Secondary Dystonia
Cambridge University Press eBooks·2025
Myeloid cell–specific loss of NPC1 in mice recapitulates microgliosis and neurodegeneration in patients with Niemann-Pick type C disease
Science Translational Medicine·2024· 15 cited
Neurodegeneration with brain iron accumulation
Elsevier eBooks·2024· 1 cited
Translating Therapeutic Strategies for Genetic Parkinson’s Disease Syndromes
Neuromethods·2024
Assessment of the reliability, responsiveness, and meaningfulness of the scale for the assessment and rating of ataxia (SARA) for lysosomal storage disorders
Journal of Neurology·2024· 6 citedOpen Access
Assessment of the Reliability, Responsiveness, and Meaningfulness of the Scale for the Assessment and Rating of Ataxia (SARA) for Lysosomal Storage Disorders
2024Open Access
Movement Disorders in Patients with Subacute Sclerosing Panencephalitis: A Systematic Review
Movement Disorders Clinical Practice·2024· 17 citedOpen Access
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study
Movement Disorders·2024· 11 citedOpen Access
Definition, diagnosis and classification of infection-related movement disorders: Consensus proposal
Parkinsonism & Related Disorders·2024· 12 cited
From enrollment to exams: Perceived stress dynamics among first-year physics students
arXiv (Cornell University)·2024Open Access
page 1 of 35Next →

Frequent Co-authors

Kailash P. Bhatia(30), John Hardy(10), Henry Houlden(9), María Stamelou(6), Petra Schwingenschuh(6), Niall Quinn(6), Günther Deuschl(6), Coro Paisán‐Ruíz(5), Nicholas Wood(5), John C. Rothwell(5), Alexander Münchau(4), Mark J. Edwards(4), Petr Dušek(4), Andrew J. Lees(4), Andrew Singleton(3), Thomas Gasser(3), Roy N. Alcalay(3), José Brás(3), Gavin Charlesworth(3), Abi Li(2)